Skip to main content
. 2020 Nov 2;70(5):1277–1289. doi: 10.1007/s00262-020-02750-1

Fig. 2.

Fig. 2

Granzyme B in peripheral blood mononuclear cells (GrB-PBMC) in ovarian and lung tumors. a The expression of GrB-PBMC was compared between patients with nonmalignant lesions (ovarian tumors and leiomyomas), lung cancer, and ovarian cancer. b GrB-PBMC in ovarian and lung cancer depending on the stage of malignancy. Ovarian tumors were staged according to FIGO (International Federation of Gynecology and Obstetrics) system. Lung tumors were staged following the American Joint Committee on Cancer (AJCC) TNM system. c GrB-PBMC in ovarian cancer coexisting with PNS and without PNS. d GrB-PBMC in lung cancer coexisting with PNS and without PNS. e GrB-PBMC in lung cancer with and without onconeural antibodies. The central line corresponds to the median. The upper and lower “hinges” correspond to the first and third quartiles. P values are denoted as asterisks: ns—p > 0.05, *p < 0.05; **p < 0.01; ***p < 0.001, ****p < 0.0001. A statistical test is specified in the text